Insulet Corp logo

Insulet Corp

NAS:PODD (USA)   Ordinary Shares
$ 168.83 -15.38 (-8.35%) 08:08 PM EST
63.30
P/B:
17.56
Market Cap:
$ 12.88B
Enterprise V:
$ 13.59B
Volume:
2.35M
Avg Vol (2M):
821.83K
Also Trade In:
Volume:
2.35M
Avg Vol (2M):
821.83K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Insulet Corp ( ) from 2007 to Feb 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Insulet stock (PODD) PE ratio as of Feb 26 2024 is 63.3. More Details

Insulet Corp (PODD) PE Ratio (TTM) Chart

To

Insulet Corp (PODD) PE Ratio (TTM) Historical Data

Total 1237
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Insulet PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-02-27 58.0 2023-12-19 125.5
2024-02-23 63.3 2023-12-18 122.6
2024-02-22 67.8 2023-12-15 121.0
2024-02-21 66.2 2023-12-14 120.9
2024-02-20 66.0 2023-12-13 119.8
2024-02-16 65.6 2023-12-12 115.4
2024-02-15 65.5 2023-12-11 114.1
2024-02-14 64.9 2023-12-08 113.8
2024-02-13 65.3 2023-12-07 113.8
2024-02-12 66.0 2023-12-06 110.7
2024-02-09 66.2 2023-12-05 111.8
2024-02-08 67.6 2023-12-04 113.4
2024-02-07 68.3 2023-12-01 112.4
2024-02-06 68.6 2023-11-30 110.6
2024-02-05 66.5 2023-11-29 110.5
2024-02-02 66.7 2023-11-28 108.6
2024-02-01 67.2 2023-11-27 109.8
2024-01-31 65.6 2023-11-24 109.9
2024-01-30 66.0 2023-11-22 109.0
2024-01-29 68.5 2023-11-21 106.0
2024-01-26 67.2 2023-11-20 106.0
2024-01-25 68.3 2023-11-17 101.8
2024-01-24 69.1 2023-11-16 102.2
2024-01-23 70.2 2023-11-15 101.5
2024-01-22 70.8 2023-11-14 101.1
2024-01-19 70.3 2023-11-13 95.7
2024-01-18 70.1 2023-11-10 90.7
2024-01-17 69.0 2023-11-09 89.4
2024-01-16 68.6 2023-11-08 90.6
2024-01-12 68.9 2023-11-07 94.7
2024-01-11 71.3 2023-11-06 92.9
2024-01-10 70.5 2023-11-03 95.1
2024-01-09 70.3 2023-11-02 82.1
2024-01-08 69.6 2023-11-01 80.5
2024-01-05 68.0 2023-10-31 77.5
2024-01-04 68.7 2023-10-30 76.5
2024-01-03 66.9 2023-10-27 78.0
2024-01-02 71.9 2023-10-26 79.0
2023-12-29 74.6 2023-10-25 81.7
2023-12-28 75.4 2023-10-24 82.5
2023-12-27 129.5 2023-10-23 86.0
2023-12-26 129.1 2023-10-20 84.6
2023-12-22 126.4 2023-10-19 84.9
2023-12-21 128.1 2023-10-18 84.7
2023-12-20 121.6 2023-10-17 82.7

Insulet Corp (PODD) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Insulet Corp logo
Insulet Corp
NAICS : 339112 SIC : 3841
ISIN : US45784P1012

Share Class Description:

PODD: Ordinary Shares
Description
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 360,000 insulin-dependent diabetics are using it worldwide.